{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T14:32:25Z","timestamp":1775658745776,"version":"3.50.1"},"reference-count":62,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100001807","name":"Fundacao de Amparo a Pesquisa do Estado de Sao Paulo","doi-asserted-by":"publisher","award":["2015\/04780-6"],"award-info":[{"award-number":["2015\/04780-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MIRNA"],"published-print":{"date-parts":[[2019,4,29]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>The high mortality rate of breast cancer is related to the occurrence of metastasis, a process that is promoted by tumor angiogenesis. MicroRNAs are small molecules of noncoding mRNA that play a key role in gene regulation and are directly involved in the progression and angiogenesis of various tumor types, including breast cancer. Several miRNAs have been described as promoters or suppressors angiogenesis and may be associated with tumor growth and metastasis. Melatonin is an oncostatic agent with a capacity of modifying the expression of innumerable genes and miRNAs related to cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>The aim of this study was to evaluate the role of melatonin and the tumor suppressor miR- 148a-3p on angiogenesis of breast cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method:<\/jats:title><jats:p>MDA-MB-231 cells were treated with melatonin and modified with the overexpression of miR-148a-3p. The relative quantification in real-time of miR-148a-3p, IGF-IR and VEGF was performed by real-time PCR. The protein expression of these targets was performed by immunocytochemistry and immunohistochemistry. Survival, migration and invasion rates of tumor cells were evaluated. Finally, the xenograft model of breast cancer was performed to confirm the role of melatonin in the tumor.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The melatonin was able to increase the gene level of miR-148a-3p and decreased the gene and protein expression of IGF-1R and VEGF, both in vitro and in vivo. In addition, it also had an inhibitory effect on the survival, migration and invasion of breast tumor cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Our results confirm the role of melatonin in the regulation of miR-148a-3p and decrease of angiogenic factors.<\/jats:p><\/jats:sec>","DOI":"10.2174\/2211536608666190219095426","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T11:07:28Z","timestamp":1551179248000},"page":"237-247","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer"],"prefix":"10.2174","volume":"8","author":[{"given":"J\u00e9ssica Zani","family":"Lacerda","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Research in Cancer (LIMC), Medical School of Sao Jose do Rio Preto (FAMERP), Sao Jose do Rio Preto (SP), Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia Carvalho","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Research in Cancer (LIMC), Medical School of Sao Jose do Rio Preto (FAMERP), Sao Jose do Rio Preto (SP), Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Camargo","family":"Lopes","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Research in Cancer (LIMC), Medical School of Sao Jose do Rio Preto (FAMERP), Sao Jose do Rio Preto (SP), Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s Felipe","family":"Aristiz\u00e1bal-Pach\u00f3n","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetics and Bioinformatics (LGMB), Faculty of Medicine of Ribeirao Preto, University of Sao Paulo (FMRP\/USP), Ribeirao Preto (SP), Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio Chaim","family":"Bajgelman","sequence":"additional","affiliation":[{"name":"Laboratory of Biosciences of the National Center of Research in Energy and Materials (LNBio\/CNPEM), Campinas (SP), Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thaiz Ferraz","family":"Borin","sequence":"additional","affiliation":[{"name":"Georgia Cancer Center, Augusta University, 1120 15th Street, Augusta, GA 30912, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora Aparecida Pires","family":"de Campos Zuccari","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Research in Cancer (LIMC), Medical School of Sao Jose do Rio Preto (FAMERP), Sao Jose do Rio Preto (SP), Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","author":"","year":"2018","unstructured":". , , INCA - Instituto Nacional de Cancer INCA , 2018"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1005740222307","volume":"16","author":"Walker R.A.","year":"1997","unstructured":"Walker RA, Jones JL, Chappell S, Walsh T, Shaw JA. Cancer Metastasis Ver, Molecular pathology of breast cancer and its application to clinical management.,, 1997, 16,, 5-27,","journal-title":"Cancer Metastasis Ver"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/joim.12084","volume":"274","author":"Redig A.J.","year":"2013","unstructured":"Redig AJ, McAllister SS. J Intern Med, Breast cancer as a systemic disease: a view of metastasis.,, 2013, 274,, 113-126,","journal-title":"J Intern Med"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.5858\/2008-132-1008-TAATFE","volume":"132","author":"Hicks D.G.","year":"2008","unstructured":"Hicks DG, Kulkarni S. Arch Pathol Lab Med, Trastuzumab as adjuvant therapy for early breast cancer: the importance of accurate human epidermal growth factor receptor 2 testing.,, 2008, 132,, 1008-1015,","journal-title":"Arch Pathol Lab Med"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-079X.2009.00742.x","volume":"48","author":"Park S.Y.","year":"2010","unstructured":"Park SY, Jang WJ, Yi EY. J Pineal Res, Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia.,, 2010, 48,, 178-184,","journal-title":"J Pineal Res"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/j.semcancer.2015.01.001","volume":"35","author":"Wang Z.","year":"2015","unstructured":"Wang Z, Dabrosin C, Yin X. Semin Cancer Biol, Broad targeting of angiogenesis for cancer prevention and therapy.,, 2015, 35,, S224-S243,","journal-title":"Semin Cancer Biol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.18632\/oncotarget.2509","volume":"6","author":"Danza K.","year":"2015","unstructured":"Danza K, De Summa S, Pinto R. Oncotarget, MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis.,, 2015, 6,, 471-483,","journal-title":"Oncotarget"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","volume":"353","author":"Calin G.A.","year":"2005","unstructured":"Calin GA, Ferracin M, Cimmino A. N Engl J Med, A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.,, 2005, 353,, 1793-1801,","journal-title":"N Engl J Med"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature06174","volume":"449","author":"Ma L.","year":"2007","unstructured":"Ma L, Teruya-Feldstein J, Weinberg RA. Nature, Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.,, 2007, 449,, 682-688,","journal-title":"Nature"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.7150\/thno.11543","volume":"5","author":"Bertoli G.","year":"2015","unstructured":"Bertoli G, Cava C, Castiglioni I. Theranostics, MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer.,, 2015, 5,, 1122-1143,","journal-title":"Theranostics"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.gde.2009.04.002","volume":"19","author":"Wang S.","year":"2009","unstructured":"Wang S, Olson EN. Curr Opin Genet Dev, AngiomiRs-key regulators of angiogenesis.,, 2009, 19,, 205-211,","journal-title":"Curr Opin Genet Dev"},{"key":"ref=12","first-page":"660","volume":"34","author":"Di Bella G.","year":"2013","unstructured":"Di Bella G, Mascia F, Ricchi A, Colori B. Neuroendocrinol Lett, Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report.,, 2013, 34,, 660-668,","journal-title":"Neuroendocrinol Lett"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.32635\/2176-9745.RBC.2005v51n1.1997","volume":"51","author":"Sousa-Neto J.A.","year":"2005","unstructured":"Sousa-Neto JA, Scaldaferri PM. Rev Bras Cancerol, Melatonina e c\u00e2ncer -revis\u00e3o da literatura.,, 2005, 51,, 49-58,","journal-title":"Rev Bras Cancerol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jpi.12007","volume":"54","author":"Alvarez-Garc\u00eda V.","year":"2013","unstructured":"Alvarez-Garc\u00eda V, Gonz\u00e1lez A, Alonso-Gonz\u00e1lez C, Mart\u00ednez-Campa C, Cos S. J Pineal Res, Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells.,, 2013, 54,, 373-380,","journal-title":"J Pineal Res"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"e85311","DOI":"10.1371\/journal.pone.0085311","volume":"9","author":"Jardim-Perassi B.V.","year":"2014","unstructured":"Jardim-Perassi BV, Arbab AS, Ferreira LC. PLoS One, Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer.,, 2014, 9,, e85311-,","journal-title":"PLoS One"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-079X.2008.00645.x","volume":"46","author":"Cucina A.","year":"2009","unstructured":"Cucina A, Proietti S, D\u2019Anselmi F. J Pineal Res, Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells.,, 2009, 46,, 172-180,","journal-title":"J Pineal Res"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-079X.2009.00684.x","volume":"47","author":"Girgert R.","year":"2009","unstructured":"Girgert R, Hanf V, Emons G, Gr\u00fcndker C. J Pineal Res, Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.,, 2009, 47,, 23-31,","journal-title":"J Pineal Res"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.canlet.2008.04.001","volume":"268","author":"Mart\u00ednez-Campa C.M.","year":"2008","unstructured":"Mart\u00ednez-Campa CM, Alonso-Gonz\u00e1lez C, Mediavilla MD, Cos S, Gonz\u00e1lez A, Sanchez-Barcelo EJ. Cancer Lett, Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells.,, 2008, 268,, 272-277,","journal-title":"Cancer Lett"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-079X.2011.00896.x","volume":"51","author":"Lee S.E.","year":"2011","unstructured":"Lee SE, Kim SJ, Youn J-P, Hwang SY, Park C-S, Park YS. J Pineal Res, MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect.,, 2011, 51,, 345-352,","journal-title":"J Pineal Res"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-4598-12-43","volume":"12","author":"Chen Y.","year":"2013","unstructured":"Chen Y, Song Y-X, Wang Z-N. Mol Cancer, The microRNA-148\/152 family: multi-faceted players.,, 2013, 12,, 43-,","journal-title":"Mol Cancer"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/eji.201747132","volume":"47","author":"Friedrich M.","year":"2017","unstructured":"Friedrich M, Pracht K, Mashreghi M-F, J\u00e4ck H-M, Radbruch A, Seliger B. Eur J Immunol, The role of the miR-148\/-152 family in physiology and disease.,, 2017, 47,, 2026-2038,","journal-title":"Eur J Immunol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jmcb\/mjs049","volume":"5","author":"Xu Q.","year":"2013","unstructured":"Xu Q, Jiang Y, Yin Y. J Mol Cell Biol, A regulatory circuit of miR- 148 a \/ 152 and DNMT 1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS 1.,, 2013, 5,, 3-13,","journal-title":"J Mol Cell Biol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1349-7006.2009.01385.x","volume":"101","author":"Hiroki E.","year":"2010","unstructured":"Hiroki E, Akahira J, Suzuki F. Cancer Sci, Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas.,, 2010, 101,, 241-249,","journal-title":"Cancer Sci"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1158\/0008-5472.CAN-11-0364","volume":"71","author":"Tsuruta T.","year":"2011","unstructured":"Tsuruta T, Kozaki K, Uesugi A. Cancer Res, miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.,, 2011, 71,, 6450-6462,","journal-title":"Cancer Res"},{"key":"ref=25","first-page":"881","volume":"51","author":"Braconi C.","year":"2010","unstructured":"Braconi C, Huang N, Patel T. Hepatology, MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes.,, 2010, 51,, 881-890,","journal-title":"Hepatology"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1261\/rna.2192803","volume":"9","author":"Stewart S.A.","year":"2003","unstructured":"Stewart SA, Dykxhoorn DM, Palliser D. RNA, Lentivirus-delivered stable gene silencing by RNAi in primary cells.,, 2003, 9,, 493-501,","journal-title":"RNA"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"Bustin S.A.","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA. Clin Chem, The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.,, 2009, 55,, 611-622,","journal-title":"Clin Chem"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jmcb\/mjs049","volume":"5","author":"Xu Q.","year":"2013","unstructured":"Xu Q, Jiang Y, Yin Y. J Mol Cell Biol, A regulatory circuit of miR-148a\/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.,, 2013, 5,, 3-13,","journal-title":"J Mol Cell Biol"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/bcr589","volume":"5","author":"Boudreau N.","year":"2003","unstructured":"Boudreau N, Myers C. Breast Cancer Res, Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment.,, 2003, 5,, 140-146,","journal-title":"Breast Cancer Res"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcdb.2015.02.016","volume":"40","author":"Tominaga N.","year":"2015","unstructured":"Tominaga N, Katsuda T, Ochiya T. Semin Cell Dev Biol, Micromanaging of tumor metastasis by extracellular vesicles.,, 2015, 40,, 52-59,","journal-title":"Semin Cell Dev Biol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jpi.12270","volume":"60","author":"Borin T.F.","year":"2016","unstructured":"Borin TF, Arbab AS, Gelaleti GB. J Pineal Res, Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression.,, 2016, 60,, 3-15,","journal-title":"J Pineal Res"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lfs.2017.06.013","volume":"183","author":"Gelaleti G.B.","year":"2017","unstructured":"Gelaleti GB, Borin TF, Maschio-Signorini LB. Life Sci, Efficacy of melatonin, IL-25 and siIL-17B in tumorigenesis-associated properties of breast cancer cell lines.,, 2017, 183,, 98-109,","journal-title":"Life Sci"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2174\/1871520616666160923093229","volume":"17","author":"Lopes J.R.","year":"2017","unstructured":"Lopes JR, Kavagutti M da S, de Medeiros FAF. Anticancer Agents Med Chem, de Campos Zuccari DAP. Evaluation of melatonin effect on human breast cancer stem cells using a threedimensional growth method of mammospheres.,, 2017, 17,, 961-965,","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/1871520615666150511094201","volume":"16","author":"Jardim-Perassi B.V.","year":"2016","unstructured":"Jardim-Perassi BV, Louren\u00e7o MR, Doho GM. Anticancer Agents Med Chem, Melatonin regulates angiogenic factors under hypoxia in breast cancer cell lines.,, 2016, 16,, 347-348,","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.2174\/1871520616666160422105920","volume":"16","author":"Maschio-Signorini L.B.","year":"2016","unstructured":"Maschio-Signorini LB, Gelaleti GB, Moschetta MG. Anticancer Agents Med Chem, Melatonin regulates angiogenic and inflammatory proteins in MDA-MB-231 cell line and in co-culture with cancer-associated fibroblasts.,, 2016, 16,, 1474-1484,","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-079X.1991.tb00007.x","volume":"10","author":"Cos S.","year":"1991","unstructured":"Cos S, Blask DE, Lemus-Wilson A, Hill AB. J Pineal Res, Effects of melatonin on the cell cycle kinetics and \u201cestrogen-rescue\u201d of MCF-7 human breast cancer cells in culture.,, 1991, 10,, 36-42,","journal-title":"J Pineal Res"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-079X.2004.00162.x","volume":"37","author":"Kilic E.","year":"2004","unstructured":"Kilic E, Kilic \u00dc, Reiter RJ, Bassetti CL, Hermann DM. J Pineal Res, Prophylactic use of melatonin protects against focal cerebral ischemia in mice: role of endothelin converting enzyme-1.,, 2004, 37,, 247-251,","journal-title":"J Pineal Res"},{"key":"ref=38","first-page":"45","volume":"22","author":"Lissoni P.","year":"2001","unstructured":"Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni GJ. Neuroendocrinol Lett, Anti-angiogenic activity of melatonin in advanced cancer patients.,, 2001, 22,, 45-47,","journal-title":"Neuroendocrinol Lett"},{"key":"ref=39","first-page":"433","volume":"39","author":"","year":"2017","unstructured":". Oncol Rep, Alicia Gonz\u00e1lez-Gonz\u00e1lez, Alicia Gonz\u00e1lez, Carolina Alonso- Gonz\u00e1lez, Javier Men\u00e9ndez-Men\u00e9ndez Carlos Mart\u00ednez-Campa SC. Complementary actions of melatonin on angiogenic factors, the angiopoietin\/Tie2 axis and VEGF, in co-cultures of human endothelial and breast cancer cells.,, 2017, 39,, 433-441,","journal-title":"Oncol Rep"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.0959-9673.2006.00474.x","volume":"87","author":"Miller S.C.","year":"2006","unstructured":"Miller SC, Pandi-Perumal SR, Pandi PSR, Esquifino AI, Cardinali DP, Maestroni GJM. Int J Exp Pathol, The role of melatonin in immuno-enhancement: potential application in cancer.,, 2006, 87,, 81-87,","journal-title":"Int J Exp Pathol"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/0008-5472.CAN-16-2529","volume":"77","author":"Das R.","year":"2017","unstructured":"Das R, Gregory PA, Fernandes RC. Cancer Res, MicroRNA-194 promotes prostate cancer metastasis by inhibiting SOCS.,, 2017, 77,, 1021-1034,","journal-title":"Cancer Res"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/ijms18091960","volume":"18","author":"Smolle M.A.","year":"2017","unstructured":"Smolle MA, Leithner A, Posch F, Szkandera J, Liegl-Atzwanger B, Pichler M. Int J Mol Sci, MicroRNAs in different histologies of soft tissue sarcoma: a comprehensive review.,, 2017, 18,, 1960-,","journal-title":"Int J Mol Sci"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.canlet.2017.11.022","volume":"414","author":"Qu S.","year":"2018","unstructured":"Qu S, Liu Z, Yang X. Cancer Lett, The emerging functions and roles of circular RNAs in cancer.,, 2018, 414,, 301-309,","journal-title":"Cancer Lett"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.livres.2017.03.003","volume":"1","author":"Kennedy L.","year":"2017","unstructured":"Kennedy L, Francis H, Meng F, Glaser S, Alpini G. Liver Res, Diagnostic and therapeutic potentials of microRNAs in cholangiopathies.,, 2017, 1,, 34-41,","journal-title":"Liver Res"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2174\/1573403X12666160301120642","volume":"12","author":"Duggal B.","year":"2016","unstructured":"Duggal B, Gupta MK, Naga PSV. Curr Cardiol Rev, Potential role of microRNAs in cardiovascular disease: are they up to their hype?,, 2016, 12,, 304-310,","journal-title":"Curr Cardiol Rev"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.3390\/ijms19092687","volume":"19","author":"Wang T.H.","year":"2018","unstructured":"Wang TH, Hsueh C, Chen CC. Int J Mol Sci, Melatonin inhibits the progression of hepatocellular carcinoma through microRNA let7i-3p mediated RAF1 reduction.,, 2018, 19,, 2687-,","journal-title":"Int J Mol Sci"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.bbrc.2015.01.117","volume":"458","author":"Kim S.J.","year":"2015","unstructured":"Kim SJ, Kang HS, Lee JH. Biochem Biophys Res Commun, Melatonin ameliorates ER stress-mediated hepatic steatosis through miR-23a in the liver.,, 2015, 458,, 462-469,","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"20532","DOI":"10.18632\/oncotarget.7978","volume":"7","author":"Mori F.","year":"2016","unstructured":"Mori F, Ferraiuolo M, Santoro R. Oncotarget, Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects.,, 2016, 7,, 20532-20548,","journal-title":"Oncotarget"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/dna.2017.4040","volume":"37","author":"Zhu C.","year":"2018","unstructured":"Zhu C, Huang Q, Zhu H. DNA Cell Biol, Melatonin inhibits the proliferation of gastric cancer cells through regulating the miR-16-5p-Smad3 pathway.,, 2018, 37,, 244-252,","journal-title":"DNA Cell Biol"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.biopha.2017.07.010","volume":"93","author":"Gu J.","year":"2017","unstructured":"Gu J, Lu Z, Ji C. Biomed Pharmacother, Melatonin inhibits proliferation and invasion via repression of miRNA-155 in glioma cells.,, 2017, 93,, 969-975,","journal-title":"Biomed Pharmacother"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.lfs.2018.07.012","volume":"208","author":"Marques J.H.M.","year":"2018","unstructured":"Marques JHM, Mota AL, Oliveira JG. Life Sci, Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: In vivo and in vitro studies.,, 2018, 208,, 131-138,","journal-title":"Life Sci"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12885-017-3298-1","volume":"17","author":"Mu J.","year":"2017","unstructured":"Mu J, Zhu D, Shen Z. BMC Cancer, The repressive effect of miR-148a on Wnt\/-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells.,, 2017, 17,, 307-,","journal-title":"BMC Cancer"},{"key":"ref=53","first-page":"3349","volume":"9","author":"Li F.","year":"2016","unstructured":"Li F, Liu W, Song Z, Chang D. Int J Clin Exp Pathol, miR-148a overexpression inhibits cell proliferation and induces cell apoptosis by suppressing the Wnt\/-catenin signal pathway in breast cancer MCF-7 cells.,, 2016, 9,, 3349-3356,","journal-title":"Int J Clin Exp Pathol"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4103\/0973-1482.150420","volume":"12","author":"Huang M-X.","year":"2016","unstructured":"Huang M-X. J Cancer Res Ther, Down-expression of circulating micro ribonucleic acid (miRNA)-148\/152 family in plasma samples of non-small cell lung cancer patients.,, 2016, 12,, 671-,","journal-title":"J Cancer Res Ther"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3727\/096504016X14685034103275","volume":"24","author":"Zhao M.","year":"2016","unstructured":"Zhao M, Su Z, Zhang S, Zhuang L, Xie Y, Li X. Oncol Res, Suppressive role of microRNA-148a in cell proliferation and invasion in ovarian cancer through targeting transforming growth factor-b-induced 2.,, 2016, 24,, 353-360,","journal-title":"Oncol Res"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.bjc.6605336","volume":"101","author":"Mart\u00ednez-Campa C.","year":"2009","unstructured":"Mart\u00ednez-Campa C, Gonz\u00e1lez A, Mediavilla MD. Br J Cancer, Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells.,, 2009, 101,, 1613-1619,","journal-title":"Br J Cancer"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1600-079X.2011.00896.x","volume":"51","author":"Lee S.E.","year":"2011","unstructured":"Lee SE, Kim SJ, Youn J-P, Hwang SY, Park C-S, Park YS. J Pineal Res, MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect.,, 2011, 51,, 345-352,","journal-title":"J Pineal Res"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bbrc.2018.05.167","volume":"502","author":"Ge H.","year":"2018","unstructured":"Ge H, Shrestha A, Liu C, Wu P, Cheng B. Biochem Biophys Res Commun, MicroRNA 148a-3p promotes thrombospondin-4 expression and enhances angiogenesis during tendinopathy development by inhibiting Kr\u00fcppel-like factor 6.,, 2018, 502,, 276-282,","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12282-016-0690-7","volume":"24","author":"Nooshinfar E.","year":"2017","unstructured":"Nooshinfar E, Safaroghli-Azar A, Bashash D, Akbari ME. Breast Cancer, Melatonin, an inhibitory agent in breast cancer.,, 2017, 24,, 42-51,","journal-title":"Breast Cancer"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/bcr2794","volume":"12","author":"Mao L.","year":"2010","unstructured":"Mao L, Yuan L, Slakey LM, Jones FE, Burow ME, Hill SM. Breast Cancer Res, Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.,, 2010, 12,, R107-,","journal-title":"Breast Cancer Res"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3892\/or.2015.4502","volume":"35","author":"Jiang Q.","year":"2016","unstructured":"Jiang Q, He M, Ma M-T. Oncol Rep, MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1.,, 2016, 35,, 1425-1432,","journal-title":"Oncol Rep"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s13277-015-3926-9","volume":"37","author":"Xue J.","year":"2016","unstructured":"Xue J, Chen Z, Gu X, Zhang Y, Zhang W. Tumour Biol, MicroRNA-148a inhibits migration of breast cancer cells by targeting MMP-13.,, 2016, 37,, 1581-1590,","journal-title":"Tumour Biol"}],"container-title":["MicroRNA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T23:12:23Z","timestamp":1694646743000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170077\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4,29]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2211536608666190219095426","relation":{},"ISSN":["2211-5366"],"issn-type":[{"value":"2211-5366","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}